- Home
- IOVA vs PTLO Comparison
IOVA vs PTLO Comparison
Compare IOVA & PTLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- PTLO
- Stock Information
- Founded
- IOVA 2007
- PTLO 1963
- Country
- IOVA United States
- PTLO United States
- Employees
- IOVA N/A
- PTLO N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- PTLO Restaurants
- Sector
- IOVA Health Care
- PTLO Consumer Discretionary
- Exchange
- IOVA Nasdaq
- PTLO Nasdaq
- Market Cap
- IOVA 771.4M
- PTLO 829.2M
- IPO Year
- IOVA N/A
- PTLO 2021
- Fundamental
- Price
- IOVA $1.88
- PTLO $11.40
- Analyst Decision
- IOVA Buy
- PTLO Buy
- Analyst Count
- IOVA 10
- PTLO 8
- Target Price
- IOVA $12.22
- PTLO $14.25
- AVG Volume (30 Days)
- IOVA 10.5M
- PTLO 1.8M
- Earning Date
- IOVA 08-07-2025
- PTLO 08-05-2025
- Dividend Yield
- IOVA N/A
- PTLO N/A
- EPS Growth
- IOVA N/A
- PTLO 8.11
- EPS
- IOVA N/A
- PTLO 0.43
- Revenue
- IOVA $212,679,000.00
- PTLO $721,160,000.00
- Revenue This Year
- IOVA $86.62
- PTLO $12.30
- Revenue Next Year
- IOVA $69.95
- PTLO $13.99
- P/E Ratio
- IOVA N/A
- PTLO $26.90
- Revenue Growth
- IOVA 11070.12
- PTLO 4.57
- 52 Week Low
- IOVA $1.64
- PTLO $8.38
- 52 Week High
- IOVA $12.51
- PTLO $15.78
- Technical
- Relative Strength Index (RSI)
- IOVA 47.47
- PTLO 44.83
- Support Level
- IOVA $1.68
- PTLO $11.78
- Resistance Level
- IOVA $2.02
- PTLO $12.23
- Average True Range (ATR)
- IOVA 0.11
- PTLO 0.41
- MACD
- IOVA 0.03
- PTLO -0.03
- Stochastic Oscillator
- IOVA 61.42
- PTLO 35.76
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About PTLO Portillo's Inc.
Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. It owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, Barnelli's pasta, sides and soup, and desserts and shakes.